Cite

HARVARD Citation

    Lacouture, M. et al. (2021). Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines. Oncologist. pp. e316-e326. [Online]. 
  
Back to record